insights_auto
Why is CSBR down 4.21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
$ 4.40
arrow_downward
-4.21%(-0.19) 1D
11-р сарын 19, 14:15:36 (GMT-5) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$ 4.47
High
$ 4.47
Low
$ 4.40
Mkt. cap
61.24 сая
Avg. vol.
6.90 мян
Volume
2.13 мян
52-wk high
$ 8.31
52-wk low
$ 4.40
EPS
-$ 0.08
Beta
0.47
Shares outstanding
13.92 сая
No. of employees
217
Open
$ 4.47
High
$ 4.47
Low
$ 4.40
Mkt. cap
61.24 сая
Avg. vol.
6.90 мян
Volume
2.13 мян
52-wk high
$ 8.31
52-wk low
$ 4.40
EPS
-$ 0.08
Beta
0.47
Shares outstanding
13.92 сая
No. of employees
217
News stories
From web sources and news partners
BeInCrypto
·
1 цагийн өмнө
S&P 500 упал на 1% и более 25 раз за 2026 год: паниковать рано
Techora.ru
·
3 цагийн өмнө
Акции Netskope удвоились за полгода, обогнав S&P 500
БКС Экспресс
·
12 цагийн өмнө
О сильных трендах в S&P 500, Brent, Gold, NG и TTF
BeInCrypto
·
4 цагийн өмнө
Пугающий сигнал S&P 500: что было с рынком после него в прошлом
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, Нью Жерси, Америкийн Нэгдсэн Улс
SectorHealth Care
Industry-
Websitechampionsoncology.com